This trial tests the effectiveness of an experimental drug for treating migraines in adults and children.
2 Primary · 0 Secondary · Reporting Duration: Week 4 and Week 16
Experimental Treatment
12 Total Participants · 2 Treatment Groups
Primary Treatment: Open-Label CDCA 250 mg TID · Has Placebo Group · Phase 3
Age Any Age · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: